Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Biofrontera submits final documents to address BF-200 ALA NDA

Sep. 23, 2011

Pilot trial investigates new protocol for treatment of severe pemphigus

Sep. 23, 2011

Sanofi Pasteur and UC San Diego to collaborate on immunological approach to acne

Sep. 21, 2011

BioLineRx receives European confirmation of regulatory pathway for BL-5010

Sep. 19, 2011

Several trials assess Anacor's boron-based therapies in healthy subjects and psoriasis

Sep. 16, 2011

Dynavax Technologies receives NIAID grant

Sep. 13, 2011

FDA expands indication of Baxter's Artiss

Sep. 6, 2011

Hybrigenics receives approval and funding for phase II inecalcitol trial in France

Sep. 6, 2011

Kuros Biosurgery completes enrollment in diabetic foot ulcer study

Sep. 1, 2011

GSK receives grant to advance dermal treatment based on Starpharma's dendrimers

Aug. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...